We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Awareness Technology, Inc.

  Gold Awareness Technology, Inc. provides clinical laboratory instrumentation, reagents and assays for small-to-medium-volu... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
22 Oct 2020 - 25 Oct 2020
Virtual Venue
27 Oct 2020 - 31 Oct 2020
Virtual Venue
28 Oct 2020 - 30 Oct 2020
Virtual Venue

Awareness Technology Announces ChemWell RPR Analyzer - The Most Significant Innovation in Syphilis Testing in Last 30 Years

By LabMedica International staff writers
Posted on 17 Jul 2020
Print article
Image: ChemWell RPR Analyzer (Photo courtesy of Awareness Technology, Inc.)
Image: ChemWell RPR Analyzer (Photo courtesy of Awareness Technology, Inc.)
Awareness Technology, Inc. (Palm City, FL, USA) has announced the most significant innovation in syphilis testing in the last 30 years with the launch of the ChemWell RPR automated nontreponemal analyzer for the detection of syphilis.

Awareness is an international IVD company that develops, manufactures, and markets high quality in-vitro diagnostic instrumentation, and diagnostic test kits. The company’s instrument portfolio includes biochemistry, ELISA, chemiluminescence, imaging analytics, electrolyte instruments, and supportive equipment. Awareness’ diagnostic test kit portfolio includes ELISA kits with a focus on autoimmune and infectious disease testing, biochemistry test kits, and allergy screening kits, which support over 200 specific allergens.

Laboratories can now automate nontreponemal testing and drive significant operational efficiencies while minimizing false-positive results with Awareness’ ChemWell RPR automated nontreponemal analyzer for the detection of syphilis. Designed to work with carbon antigen, the RPR analyzer uses four standard 48 well microwell plates instead of manual RPR cards to analyze up to 192 samples per hour without any user intervention. It utilizes a high resolution imaging system which captures the reaction taking place in each of the back-lit wells that are interpreted by a proven algorithm and provide an accurate and reliable negative or positive result based on the captured images. It can perform visual identification of positive or negative reaction with a sensitivity of 98.8% and a specificity of 99.8%.

An additional test can be run on positive samples to determine titers up to 1:2048 dilution for therapeutic monitoring. The software is included with the user-friendly system at no additional cost and features an intuitive interface that allows for easy navigation and use. Automated features such as fluid handling, mixing, timing, image capture, image processing, and reporting are all handled by the software.

Print article
BIOHIT  Healthcare OY


Molecular Diagnostics

view channel
Image: Schematic view of the placenta (Photo courtesy of Wikimedia Commons)

Analysis of Placental Cell Free DNA and RNA Predicts Gestational Complications

A recent paper revealed that circulating cell-free nucleic acids (DNA and RNA) shed from the placenta into the mother's blood during the first trimester of pregnancy could be used to predict potentially... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.